ArticleSleep & breathing = Schlaf & Atmung2025
A Preliminary Integrated Metabolomics Analysis Identifies Retrograde Endocannabinoid Signaling Shift in Severe OSA Patients.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThe systemic influence of obstructive sleep apnea(OSA), particularly in those with severe OSA (sOSA), has frequently been disregarded. An investigation was conducted to examine the variations of reactive oxygen species (ROS) and metabolomic drifts, as well as their interrelations, in adult OSA patients.
methodsA total of 22 male patients were enrolled after undergoing polysomnography (PSG), and blood samples were obtained. Following the measurement of ROS levels in polymorphonuclear neutrophils (PMNs), plasma samples were combined and analyzed using both Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS).
resultsPatients with sOSA had a higher body mass index (BMI) (p = 0.005) and more negative PSG measures compared to those with mild/moderate OSA (mOSA). Although there was no remarkable difference in neutrophil ROS between the mOSA and sOSA group, further analysis indicated sleep fragmentation was associated with ROS production(p = 0.043 for N3%, p < 0.01 for Arousal Index). Integrated metabolomics analysis revealed significant alterations in 59 metabolites from GC-MS and 27 metabolites from LC-MS in sOSA patients. These substantial changes perturbed various pathways, including the FoxO signaling pathway and its upstream PI3K-Akt signaling pathway, and so on. Notably, the retrograde endocannabinoid signaling pathway was the sole common pathway identified in both GC-MS and LC-MS data.
conclusionsThis study sheds light on the systemic impact of OSA, particularly in severe cases, by uncovering extensive disturbance of metabolic pathways. The identification of retrograde endocannabinoid signaling shifts in severe OSA adults highlights its potential impact in the sleep disorder and its broader repercussions in the body.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.